Blood Pressure Targets by Age
Introduction to Blood Pressure Management
- The American College of Cardiology recommends a target blood pressure of <130/80 mmHg for adults with hypertension or 10-year ASCVD risk ≥10% 1, 3
- The European Society of Cardiology recommends an initial default systolic target of 120-129 mmHg in most adults if tolerated, with 120 mmHg being the optimal point in this range 2, 3
Adults Under 65 Years
- The American College of Cardiology/American Heart Association guidelines provide a strong (Class I) recommendation for <130/80 mmHg in adults with known CVD or ≥10% 10-year ASCVD risk 1, 4
- Diastolic blood pressure should target 70-79 mmHg optimally, though systolic control takes priority even when diastolic falls below this range if treatment is tolerated 2, 5
Adults Aged 65-79 Years
- The American College of Cardiology/American Heart Association guidelines provide a Class I recommendation for SBP <130 mmHg in adults ≥65 years with average SBP ≥130 mmHg, based on high-quality evidence including SPRINT 6, 1
- In SPRINT, adults aged 75 and older treated to intensive SBP goal had 34% lower risk of major cardiovascular events compared to standard target, with benefits consistent regardless of baseline frailty status 6
Adults Aged ≥80 Years
- The European Society of Cardiology recommends considering a more lenient target (e.g., <140/90 mmHg) for individuals ≥85 years with pretreatment symptomatic orthostatic hypotension 2
- The National Institute for Health and Care Excellence guidelines recommend a target below 150/90 mmHg for adults aged 80 years and older, based largely on the HYVET study 7
Special Populations Requiring Modified Targets
Patients with Chronic Kidney Disease
- The American Journal of Kidney Diseases recommends a target <130/80 mmHg for patients with CKD, with ACE inhibitor or ARB if albuminuria present 6, 3, 8
Patients with Diabetes
- The American Journal of Kidney Diseases recommends a target <130/80 mmHg for patients with diabetes and hypertension 6, 3, 8
- Intensive SBP lowering should not be combined with intensive glucose lowering (hemoglobin A1c target <7%) based on ACCORD BP trial findings showing increased serious adverse events with dual intensive therapy 6
Patients with History of Stroke/TIA
- The Annals of Internal Medicine provides a weak recommendation (moderate-quality evidence) for initiating or intensifying treatment to achieve SBP <140 mmHg in adults ≥60 years with history of stroke or TIA 9
Practical Implementation Considerations
Monitoring and Titration
- After initiating treatment, follow-up should occur within the first 2 months to assess efficacy and tolerability 3, 8
- Once target BP is achieved, monitoring should occur every 3-6 months 5, 3
Medication Selection
- Two or more antihypertensive medications are typically required to achieve BP target <130/80 mmHg in most adults, especially in Black adults 6
- First-line medications include ACE inhibitors, ARBs, calcium channel blockers, and thiazide or thiazide-like diuretics 2, 3
Adverse Events and Safety
- Treatment to lower BP targets may increase specific adverse events including hypotension, electrolyte abnormalities, and acute kidney injury by 1.0-1.5% compared to standard targets 4
- However, overall serious adverse events were not increased in the intensive group compared to standard group in SPRINT, including in those aged 75 and older 4